WK86056 - New Test Method for Measuring In Vitro Drug Release from Liposomal Drug Formulations. | ASTM

Using Artificial Intelligence (AI) on ASTM standards and related intellectual property is prohibited. Violations will result in suspension of access.

Home
FAQ

Home
FAQ

Home
Membership & Participati…

/

Technical Committees

/

WK86056 - New Test Metho…

Loading...

About ASTM

Governance Global Cooperation Corporate Citizenship History Regional Offices and Websites Diversity, Equity, Inclusion & Belonging Culture & Careers

Membership & Participation

Membership Technical Committees Member Tools Meetings, Symposia & Workshops Academic Outreach Emerging Professionals Publish with ASTM Consumer Participation

Standards & Solutions

Standards & Publications Enterprise Solutions ASTM Compass®Digital Library Market Insights & Innovation Laboratory Services Training Courses Certification Cement & Concrete Reference Lab

News

Standardization News Press Releases Podcasts Español Editorial Calendar and Media Kit

Help

Contact ASTM Locations FAQ

Policies

Privacy Policy Logo Policy IP Policy Return Policy Copyright & Permissions

Copyright © 1996 - 2026 ASTM. All Rights Reserved. ASTM International, 100 Barr Harbor Drive, PO Box C700, West Conshohocken, PA, 19428-2959 USA

Work Item

ASTM WK86056

New Test Method for Measuring In Vitro Drug Release from Liposomal Drug Formulations.

1. Scope

Method for Measuring In Vitro Drug Release from Liposome Drug Formulations

Keywords

in vitro drug release, doxorubicin, liposomes

Rationale

TBD

Details

Developed by Subcommittee: E56.08

Committee: E56

Staff Manager: Frank McConnell

Related

Copyright/Permissions